A detailed history of Monte Financial Group, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Monte Financial Group, LLC holds 22,724 shares of AZN stock, worth $1.46 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares
22,724
Previous 24,795 8.35%
Holding current value
$1.46 Million
Previous $1.93 Million 8.43%
% of portfolio
0.74%
Previous 0.86%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$76.67 - $87.62 $158,783 - $181,461
-2,071 Reduced 8.35%
22,724 $1.77 Million
Q2 2024

Jul 22, 2024

BUY
$66.81 - $80.83 $350,084 - $423,549
5,240 Added 26.8%
24,795 $1.93 Million
Q1 2024

Apr 29, 2024

BUY
$61.03 - $69.57 $1.19 Million - $1.36 Million
19,555 New
19,555 $1.32 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $199B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Monte Financial Group, LLC Portfolio

Follow Monte Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monte Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monte Financial Group, LLC with notifications on news.